Arcus Biosciences (RCUS)
Develops small-molecule and antibody therapies for cancer and inflammatory diseases.
$27.81
vs last close+0.94 (+3.50%)
Something off on this page? Send us feedback.
Next report
Oct 27, 26
in 34 days
EPS estimate
−$0.94
Revenue estimate
$11.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported−$1.03−$1.14−$0.08−$1.27−$0.89−$1.02−$0.72Pending
Estimate−$1.17−$1.02−$1.14−$1.33−$1.11−$0.92−$0.89−$0.94
Surprise+12.0%−11.8%+93.4%+4.5%+19.8%−10.9%+19.2%—
RevenueReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported$26.0M$28.0M$160.0M$26.0M$33.0M$17.0M$41.0MPending
Estimate$29.4M$37.4M$32.5M$24.9M$35.7M$29.5M$22.0M$11.0M
Surprise−11.5%−25.0%+392.6%+4.3%−7.6%−42.3%+86.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2029 | −$0.20 | — | — |
| Sep 2029 | −$0.29 | — | — |
| Jun 2029 | −$0.37 | — | — |
| Mar 2029 | −$0.44 | — | — |
| Dec 2028 | −$0.48 | — | — |
| Sep 2028 | −$0.64 | — | — |
| Jun 2028 | −$0.85 | — | — |
| Mar 2028 | −$0.86 | — | — |
| Dec 2027 | −$0.93 | — | — |
| Sep 2027 | −$0.95 | — | — |
| Jun 2027 | −$1.06 | — | — |
| Mar 2027 | −$0.94 | — | — |
| Dec 2026 | −$0.88 | — | — |
| Oct 2026 | −$0.94 | — | — |
| Aug 2026 | −$0.89 | −$0.72 | +19.2% |
| May 2026 | −$0.92 | −$1.02 | −10.9% |
| Feb 2026 | −$1.11 | −$0.89 | +19.8% |
| Oct 2025 | −$1.33 | −$1.27 | +4.5% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Dec 2017 | |||
| Mar 2018 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2029 | −$0.20 | — | — | $187.0M | — | — | — |
| Sep 2029 | −$0.29 | — | — | $162.8M | — | — | — |
| Jun 2029 | −$0.37 | — | — | $139.0M | — | — | — |
| Mar 2029 | −$0.44 | — | — | $118.0M | — | — | — |
| Dec 2028 | −$0.48 | — | — | $102.5M | — | — | — |
| Sep 2028 | −$0.64 | — | — | $59.0M | — | — | — |
| Jun 2028 | −$0.85 | — | — | $147.1M | — | — | — |
| Mar 2028 | −$0.86 | — | — | $104.0M | — | — | — |
| Dec 2027 | −$0.93 | — | — | $8.0M | — | — | — |
| Sep 2027 | −$0.95 | — | — | $5.3M | — | — | — |
| Jun 2027 | −$1.06 | — | — | $6.6M | — | — | — |
| Mar 2027 | −$0.94 | — | — | $6.8M | — | — | — |
| Dec 2026 | −$0.88 | — | — | $7.0M | — | — | — |
| Oct 27, 2026 | −$0.94 | — | — | $11.0M | — | — | — |
| Aug 5, 2026 | −$0.89 | −$0.72 | +19.2% | $22.0M | $41.0M | +86.5% | +2.3% |
| May 5, 2026 | −$0.92 | −$1.02 | −10.9% | $29.5M | $17.0M | −42.3% | −0.2% |
| Feb 25, 2026 | −$1.11 | −$0.89 | +19.8% | $35.7M | $33.0M | −7.6% | −3.6% |
| Oct 28, 2025 | −$1.33 | −$1.27 | +4.5% | $24.9M | $26.0M | +4.3% | +2.1% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 21, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 5, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 2, 2019 | |||||||
| Mar 5, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 6, 2018 | |||||||
| May 9, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Mar 16, 2018 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |